Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 56.86 M62.94 M63.5 M77.94 M 261.24 M Research & development ———— — Operating income 236.73 M269.66 M260.96 M252.45 M 1.02 B Non-Operating Income, Total -1.21 M-1.21 M402 K-1.1 M -3.12 M Interest expense, net of interest capitalized 174.69 M182.14 M171.98 M181.24 M 710.04 M Non-Operating Income, excl. Interest Expenses -175.89 M-183.35 M-171.58 M-182.34 M -713.16 M Unusual income/expense ———— — Pretax income 149.89 M175.51 M165.3 M155.97 M 646.67 M Equity in earnings ———— — Taxes 37.54 M47.12 M40.62 M31.03 M 156.3 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 112.35 M128.4 M124.68 M124.95 M 490.37 M Discontinued operations ———— — Net income 112.35 M128.4 M124.68 M124.95 M 490.37 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 112.35 M128.4 M124.68 M124.95 M 490.37 M Basic earnings per share (Basic EPS) 1.992.272.22.2 8.66 Diluted earnings per share (Diluted EPS) 1.942.222.152.17 8.48 Average basic shares outstanding 56.51 M56.66 M56.72 M56.66 M — Diluted shares outstanding 56.51 M56.66 M56.72 M56.66 M — EBITDA 45.67 M62.94 M93.78 M131.67 M 334.06 M EBIT 67.37 M102.32 M109.23 M94.51 M 373.44 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) -21.7 M-39.38 M-15.45 M37.15 M -39.38 M